Search

everythinglearnresearchcommunity

for

Search:↓

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

The mutated hairless gene causes hair loss by acting as a new type of corepressor affecting thyroid hormone receptors.

Bone Morphogenetic Proteins (BMPs) help control skin health, hair growth, and color, and could potentially be used to treat skin and hair disorders.

Fibromodulin might help reduce scarring if increased in adult wounds like in fetal skin that heals without scars.

Estrogen therapy can reduce skin aging but has cancer risks.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Lampreys have a functional vitamin D receptor that may help detoxify harmful substances.

The three estrogen receptor genes are highly expressed in zebrafish neuromasts during development.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

JMJD3 and NF-κB activate Notch1, which is essential for skin cell movement and wound healing.

Human liver cells stick to hair protein materials mainly through the liver's asialoglycoprotein receptor.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

New compounds with carborane showed anti-androgen effects similar to flutamide.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Activating Notch in adult skin causes T cells and neural crest cells to gather, leading to skin issues.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

The ITGB6 gene is important for tissue repair and hair growth, and mutations can lead to enamel defects and other health issues.

Mutations in certain receptors can cause diseases and offer new treatment options.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Finasteride may improve prostate cancer treatment outcomes.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.